In the News

484 News Items found
Meryl Jacobs poses with her husband and grandkids
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a phase 2 clinical trial led by an MSK investigator.
Dr. Nancy Lee, Dr. Alan Ho, and Dr. Richard Wong review scans on a computer
ASTRO 2025 Highlights From MSK
Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.
Michel Talagrand, Maria Jasin, Carrie Lam Cheng Yuet-ngor, and Edward Stone
Q&A
Maria Jasin, a member of the Sloan Kettering Institute’s Developmental Biology Program, discusses her research.
Memorial Sloan Kettering exercise scientist Lee Jones
Q&A
People with prostate cancer can benefit from exercise in more ways than they might expect.
Hematologic oncologist Urvi Shah
Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.
Pictured: José Baselga
Announcement
Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.
MSK thoracic surgeon and lung cancer specialist David Jones.
An inherited mutation that contributes to lung cancer spread could be a target for therapies.
MSK's Mark Awad, MD, PhD, is seen smiling.
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
MSK acupuncturist Charles Rico is seen giving acupressure to patient Elizabeth Sosa at the MSK Ralph Lauren Center.
Learn how acupuncture is being used at the MSK Ralph Lauren Center in Harlem to reduce pain and other symptoms in people facing cancer.
Smiling female doctor talking to patient.
Q&A
Inheriting a mutation in the CDH1 gene can raise risk of a rare stomach cancer called hereditary diffuse gastric cancer.